Statement by EMBL, the Francis Crick Institute, and the Wellcome Sanger Institute on Brexit
Today marks the next chapter in the UK’s relationship with Europe. While we wait to see what a future relationship brings, researchers will continue to work across borders to tackle society’s most pressing problems, such as climate change, ageing, and disease.
One of EMBL’s six sites – the European Bioinformatics Institute – is located in the UK at the Wellcome Genome Campus, alongside the Sanger Institute.
All three institutions bring people together from diverse backgrounds, often across borders. This enhances science and will drive the continued success of research in the UK and Europe.
Whatever the outcome of Brexit, we will remain open and welcoming to scientists and students from around the world.
In 2019, the Crick and EMBL signed a memorandum of understanding to strengthen our pan-European scientific cooperation and advance life science for the benefit of European society. This is already stimulating cooperation between leading life science researchers working at both institutes, supporting existing collaborations and encouraging new ones. This collaboration will also bring together early-career scientists from both institutes in order to share knowledge and ideas through shared projects and joint conferences.
We all benefit from these collaborations, not just scientists. As we continue to work together across Europe, we can deliver greater benefits for people around the world.
Professor Edith Heard Director General European Molecular Biology Laboratory
Professor Sir Paul Nurse Chief Executive and Director Francis Crick Institute
Professor Sir Mike Stratton Director Wellcome Sanger Institute